• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Veracyte, Inc. (VCYT)

    -NasdaqGM
    8.04 Up 0.10(1.26%) Jan 27, 4:00PM EST
    |After Hours : 8.04 0.00 (0.00%) Jan 27, 4:50PM EST
    Add to Portfolio
    Prev Close:7.94
    Open:7.89
    Bid:N/A
    Ask:14.43 x 700
    1y Target Est:13.17
    Beta:N/A
    Earnings Date:Mar 16 - Mar 20 (Est.)
    Day's Range:7.77 - 8.20
    52wk Range:6.01 - 19.00
    Volume:42,945
    Avg Vol (3m):79,657
    Market Cap:180.95M
    P/E (ttm):N/A
    EPS (ttm):-1.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for VCYT

    Comparison

    Symbol% ChgMkt Cap
    VCYTUp 1.26%180.95M
    LHDown 0.77%9.83B
    DGXDown 0.32%10.31B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.32
    Quarterly EPS Est (Dec-14) :-0.33
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier, which ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback